Ocular Therapeutix (OCUL) Work In Process (2014 - 2026)

Ocular Therapeutix's Work In Process history runs 13 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• In Q1 2026, Work In Process fell 31.19% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 31.19% YoY), while the FY2025 annual figure was $1.7 million, up 15.58% from the prior year.
• Work In Process was $1.2 million for Q1 2026 at Ocular Therapeutix, down from $1.7 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $1.8 million in Q1 2025 to a low of $567000.0 in Q1 2022.
• Historically, Work In Process has averaged $1.1 million across 5 years, with a median of $1.0 million in 2023.
• The sharpest annual moves came in 2025 and 2026: Work In Process jumped 97.27% in 2025, then sank 31.19% in 2026.
• A 5-year view of Work In Process shows it stood at $899000.0 in 2022, then climbed by 12.57% to $1.0 million in 2023, then surged by 47.13% to $1.5 million in 2024, then increased by 15.58% to $1.7 million in 2025, then fell by 27.83% to $1.2 million in 2026.
• The last three Work In Process figures came in at $1.2 million (Q1 2026), $1.7 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.